MOH — authorised 10 June 2004
- Marketing authorisation holder: EMMAUS MEDCL
- Status: likely_approved
MOH authorised Nutrestore on 10 June 2004
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 10 June 2004.
EMMAUS MEDCL holds the Israeli marketing authorisation.